The epidemiology of travel-associated shigellosis--regional risks, seasonality and serogroups.

The epidemiology of travel-associated shigellosis--regional risks, seasonality and serogroups. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The epidemiology of travel-associated shigellosis--regional risks, seasonality and serogroups. Abstract Text:

Karl Ekdahl,Yvonne Andersson,

OBJECTIVES: To give a detailed risk estimate of contracting travel-associated shigellosis in various regions of the world. METHODS: Data on notifications of travel-associated shigellosis in Sweden 1997-2003 were compared with information on recent travel abroad from a comprehensive database based on telephone interviews with more than 160,000 Swedish travellers. RESULTS: From the national notification database 2678 patients with travel-associated shigellosis were retrieved. The highest risk of being notified with shigellosis was seen in returning travellers from India and neighbouring countries (318/100,000 travellers), East Africa (219/100,000), West Africa (120/100,000), and North Africa (76/100,000). Data on serogroup was available for 2529 isolates. Shigella sonnei was the most common serogroup (67%), followed by Shigella flexneri (26%), Shigella boydii (5%), and Shigella dysenteriae (3%). A higher risk was seen in children below the age of six, compared to older children and adults and in women compared to men. A distinct seasonal pattern was noted with the highest risk of shigellosis in July-October and the lowest in May. CONCLUSIONS: Denominator based data on reported travel-associated infections are well suited to give risk estimates per region of infection, that could be used to target high-risk groups for pre-travel advice.

The epidemiology of travel-associated shigellosis--regional risks, seasonality and serogroups. Publishing Authors By Initials

K Ekdahl,Y Andersson,

For similar human activities: travel research abstracts see: human activities: travel research

PUBMED ID PMID:

MEDLINE DATE:

The epidemiology of travel-associated shigellosis--regional risks, seasonality and serogroups. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: The Journal of infection

VOLUME: 51

Page Numbers: 222-9

Journal Abbreviation: J. Infect.

ISSN: 1532-2742

DAY: 14

MONTH: Oct

YEAR: 2005

The epidemiology of travel-associated shigellosis--regional risks, seasonality and serogroups. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7908424

The epidemiology of travel-associated shigellosis--regional risks, seasonality and serogroups. Keywords Mesh Terms:

KEYWORDS: Travel

MESH TERMS: epidemiology

Chemical & Substance for Abstract: The epidemiology of travel-associated shigellosis--regional risks, seasonality and serogroups. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The epidemiology of travel-associated shigellosis--regional risks, seasonality and serogroups.

AFFILIATION: Department of Epidemiology, Swedish Institute for Infectious Disease Control (SMI), Stockholm, Sweden. karl.ekdahl@smi.ki.se

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Infect

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The epidemiology of travel-associated shigellosis--regional risks, seasonality and serogroups Related Publications

• Assessment of bleeding after concomitant administration of antiplatelet and anticoagulant agents in lower limb arthroplasty.
• Bone Ingrowth Through Porous Titanium Granulate Around a Femoral Stem: Histological assessment in a six-month canine hemiarthroplasty model.
• Cardiac reserve in the transplanted heart: effect of a graft polymorphism in the beta1-adrenoceptor.
• Case-referent study of cystic ovaries as a risk indicator for twin calvings in dairy cows.
• Cluster of Salmonella Enteritidis in Sweden 2005-2006 - suspected source: almonds.
• Duplication of FGF3, FGF4, FGF19 and ORAOV1 causes hair ridge and predisposition to dermoid sinus in Ridgeback dogs.
• Effect of timing of dosing in relation to food intake on the pharmacokinetics of esomeprazole.
• GRAT--genome-scale rapid alignment tool.
• GTP bound to chloroplast thylakoid membranes is required for light-induced, multienzyme degradation of the photosystem II D1 protein.
• Improved survival rate for women with interval breast cancer - results from the breast cancer screening programme in Malmö, Sweden 1976-1999.
• Inclusion of regional poroelastic material properties better predicts biomechanical behavior of lumbar discs subjected to dynamic loading.
• Intracellular pathogens go extreme: genome evolution in the Rickettsiales.
• Knowledge of emergency management of avulsed teeth among young physicians and dentists.
• LUTS treatment: future treatment options.
• Lack of Pharmacokinetic Interaction between Esomeprazole and the Nonsteroidal Anti-Inflammatory Drugs Naproxen and Rofecoxib in Healthy Subjects.
• Loss-of-function mutation in carotenoid 15,15'-monooxygenase identified in a patient with hypercarotenemia and hypovitaminosis A.
• Multiple mechanisms to ameliorate the fitness burden of mupirocin resistance in Salmonella typhimurium.
• Muscarinic receptor antagonists for overactive bladder.
• Origin of mutations under selection: the adaptive mutation controversy.
• Outbreak of Salmonella Stanley in Sweden associated with alfalfa sprouts, July-August 2007.
• Pharmacokinetics of once-daily IV busulfan as part of pretransplantation preparative regimens: a comparison with an every 6-hour dosing schedule.
• Postoperative Melagatran/Ximelagatran for the Prevention of Venous Thromboembolism following Major Elective Orthopaedic Surgery : Effects of Timing of First Dose and Risk Factors for Thromboembolism and Bleeding Complications on Efficacy and Safety.
• Proteolytic processing and polarized secretion of tartrate-resistant acid phosphatase is altered in a subpopulation of metaphyseal osteoclasts in cathepsin K-deficient mice.
• Recurrence in patients with oral and oropharyngeal squamous cell carcinoma: human papillomavirus and other risk factors.
• Rho-kinase and effects of Rho-kinase inhibition on the lower urinary tract.
• Settlement size and fertility in the Nordic countries.
• Structural analysis of altered large-subunit loop-6/carboxy-terminus interactions that influence catalytic efficiency and CO2/O2 specificity of ribulose-1,5-bisphosphate carboxylase/oxygenase.
• The importance of an active ongoing debate in science.
• Treatment-resistant detrusor overactivity--underlying pharmacology and potential mechanisms.
• p16INK4a immunocytochemistry in liquid-based cervical cytology: is it feasible for clinical use?